Edelweiss Alternatives on Saturday entered into an agreement with Larsen & Toubro and Canadian Pension Plan Investment Board to pick up their 100 per cent stakes in L&T Infrastructure Development Projects at an enterprise value of Rs 6,000 crore. Edelweiss Alternatives -- an alternative ivestment fund management platform -- in a statement said that the transaction is being executed by a fund managed by Edelweiss Alternatives and it also involves absorbing the operating team. The portfolio of the target company comprises eight roads and one power transmission asset, spanning 4,900 lane kilometres and 960 circuit kilometres, respectively. Following this acquisition, the infrastructure platform will scale up to 26 assets with cumulative annual revenue of nearly Rs 2,700 crore. The platform will be a diverse mix of power transmission and substations, renewables and highway assets. Sreekumar Chatra, managing director of the infrastructure yield strategy fund, said these assets have
Noventiq did not disclosed the sum for which it acquired G7 CR Technologies India Pvt Ltd
Fresh challenge for reviving Jet as union opposes sale of assets until employees get provident fund and gratuity
Meanwhile, Jaiprakash Associates dipped 8 per cent to Rs 10.81, falling 13 per cent from its intra-day high, and Jaiprakash Power Ventures declined 5 per cent to Rs 7.90 on the BSE.
TVS Motor Company on Friday said its Singapore-based subsidiary has inked a pact to acquire Electric Vehicle (EV) related technology and assets in Germany. The company, through its wholly-owned subsidiary TVS Motor (Singapore) Pte Ltd (TVSM Singapore) has signed an agreement to acquire the assets, TVS Motor Company said in a statement. TVS Singapore will be acquiring the assets through its subsidiary BBT Vermogensverwaltungs GmbH (name proposed to be changed to Celerity Motor GmbH), it added. The purchase will help strengthen the company's expansion in the electric two-wheeler market globally, TVS Motor said. The company, however, did not disclose financial details.
Disagreement over valuation of Noida-based company which wants more from the deal, says source
Electricals and home appliances player V-Guard Industries on Friday said it will acquire Sunflame Enterprises for Rs 660 crore in an all-cash deal. The acquisition of the Delhi-based Sunflame will help V-Guard scale up its kitchen appliances business while also unlocking synergy benefits. "We have entered into a definitive agreement to acquire 100 per cent stake of Sunflame Enterprises for Rs 660 crore in an all cash deal," the Kochi-based company said in a statement. Sunflame is a debt-free company and has around Rs 50 crore cash in-hand which does not include in the deal -- implying the promoter of the selling company will take out that money before the deal is concluded. It had a topline of Rs 350 crore in FY22. The acquisition is in line with V-Guard's strategy to become a significant player in the domestic kitchen appliances segment, it added. Sunflame has a large brand portfolio which includes cooktops, chimneys, pressure cookers, mixer grinders, small kitchen appliances ...
The deal would enable Microsoft to suppress competitors to its Xbox gaming consoles and its rapidly growing subscription content and cloud-gaming business
The company will be buying a majority stake in Zywie Ventures, promoter of brand OZiva, for Rs 264.28 crore and up to 20 per cent stake in Nutritionalab for Rs 70 crore.
To acquire majority stake in OZiva maker, 19.8% in Nutritionalab
Leading FMCG maker HUL on Thursday announced the acquisition of a majority stake in OZiva and a 19.8 per cent equity in Wellbeing Nutrition with a total investment of Rs 335 crore to foray into the health and wellbeing segment. Hindustan Unilever Limited (HUL) will acquire a 51 per cent stake in Zywie Ventures Private Ltd, which owns the brand OZiva, for a consideration of Rs 264.28 crore, making its entry into the health and wellbeing segment. Besides, HUL has also announced the acquisition of a 19.8 per cent stake in Nutritionalab Pvt Ltd (Wellbeing Nutrition) for a cash consideration of Rs 70 crore. Health and wellbeing segment is a fast-evolving category in India, which according to Euromonitor Data has a total potential market size of Rs 30,000 crore. In OZiva, HUL will acquire a 51 per cent equity stake through a combination of primary infusion and secondary buyouts, said a statement from the FMCG major. "The balance 49 per cent will be acquired at the end of 36 months based
The South Asian govt's tax department has asked the bank to pay the amount on behalf of seller Fullerton Financial Holdings Pte, arguing that it should have withheld the sum during the acquisition
Conglomerate can now propose reconstitution of board, say proxy advisory firms
"But it has to have world-class capacity, and cannot be a small plant. We have a capacity of about 3 million tonnes (mt)... we are contemplating. We have to take it to 15-20 mt"
Ravish Kumar has been an integral part of NDTV for more than two decades and has been conferred with the prestigious Ramon Magsaysay award and Ramnath Goenka Excellence in Journalism Award twice
Nearly Rs 90,000 crore worth of capital expenditure has been incurred so far on various asset acquisitions and projects, with a major investment of about Rs 42,000 crore
The privately-held company has more than 175 consultants who design and deliver cloud and automation solutions
Mankind Pharma on Monday said it has acquired a majority stake in Upakarma Ayurveda, engaged in developing, manufacturing and selling ayurvedic and herbal products for an undisclosed amount. The company's decision to invest will empower Upakarma Ayurveda to develop a wider range of products and offerings, the drug firm said in a statement. "The current lifestyle has become strenuous where people find it difficult to focus on their health. To fulfil their requirements, consumers are considering Ayurvedic remedies for long-term sustenance and boosting immunity over time. "As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the emerging needs of consumers," Mankind Pharma Vice Chairman and Managing Director Rajeev Juneja said. Mankind Pharma acquired the ayurvedic soulutions firm through one of its subsidiaries. Upakarma Ayurveda Founder & Managing Director Vishal Kaushik said that with the partnership, ..
Deal expected to be closed in two-four weeks, says source
A majority stake for Rs 6K-7K cr to allow TCPL's expansion in beverage space